产品描述
青霉素/链霉素溶液,灭菌中,含有青霉素G钠盐10KU/ml,硫酸链霉素10mg/ml。该溶液用0.85%NaCl配制。在细胞培养中推荐的青霉素的工作浓度为100U/ml,链霉素的工作浓度为0.1mg/ml,即按照100倍稀释使用即可。
产品优势
本产品是细胞培养的双抗,经过滤除菌,可以直接添加到细胞培养液内。
储存条件
-20℃保存,一年有效。
注意事项
为了您的安全和健康,请穿实验服并戴一次性手套操作。
操作指南
操作方法:请参考说明书
-
Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity
Nature Immunology
IF:27.7
年份:2024
-
Nature Communications
IF:17.69
年份:2023
-
Nature Communications
IF:17.69
年份:2022
-
Nano Energy
IF:17.6
年份:2023
-
Acta Pharmaceutica Sinica B
IF:14.7
年份:2024
-
Cell Reports Medicine
IF:11.7
年份:2024
-
Acta Pharmaceutica Sinica B
IF:11.41
年份:2021
-
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Journal of Experimental & Clinical Cancer Research
IF:11.161
年份:2019
-
Environment International
IF:10.3
年份:2024
-
Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
Cell Death & Disease
IF:9.68
年份:2022
-
FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis
JCI Insight.
IF:9.48
年份:2022
-
A proteomic landscape of pharmacologic perturbations for functional relevance
Journal of Pharmaceutical Analysis
IF:8.8
年份:2023
-
Food Chemistry
IF:8.8
年份:2023
-
Food Frontiers
IF:8.444
年份:2023
-
Journal of Colloid and Interface Science
IF:8.124
年份:2021
-
International Journal of Nanomedicine
IF:7.033
年份:2023
-
Cell Death Discovery
IF:7
年份:2023
-
Vitamin A-modified ZIF-8 lipid nanoparticles for the therapy of liver fibrosis
International Journal of Pharmaceutics
IF:6.51
年份:2023
-
International Journal of Nanomedicine
IF:6.403
年份:2020
-
Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production
Front. Pharmacol
IF:5.813
年份:2021
-
International Journal of Molecular Medicine
IF:5.7
年份:2024
-
Journal of Biological Chemistry
IF:5.15
年份:2021
-
Inflammation
IF:5.1
年份:2022
-
Cellular and Molecular Neurobiology
IF:5.042
年份:2020
-
Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer
Scientific Reports
IF:4.996
年份:2023
-
p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
Frontiers in Oncology
IF:4.84
年份:2019
-
Cellular Signalling
IF:4.8
年份:2023
-
Journal of Ethnopharmacology
IF:4.8
年份:2024
-
FOXA1-Driven pathways exacerbate Radiotherapy-Induced kidney injury in colorectal cancer
International Immunopharmacology
IF:4.8
年份:2024
-
SMS2 siRNA inhibits pancreatic tumor growth by tumor microenvironment modulation
International Immunopharmacology
IF:4.8
年份:2024
-
Scientific Reports
IF:4.38
年份:2022
-
Scientific Reports
IF:3.8
年份:2024
-
Journal of Food Biochemistry
IF:3.5
年份:2024
-
Urolithiasis
IF:3.434
年份:2021
-
BMC Cancer
IF:3.4
年份:2024
-
Identification of homer protein homolog 3 as a prognostic marker of colon adenocarcinoma
Heliyon
IF:3.4
年份:2024
-
Heliyon
IF:3.4
年份:2024
-
Rab3A interacts with spastin to regulate neurite outgrowth in hippocampal neurons
Biochemical and Biophysical Research Communications
IF:3.32
年份:2023
-
NeuroMolecular Medicine
IF:3.3
年份:2024
-
PeerJ
IF:2.7
年份:2023
-
STAR Protocols
IF:1.3
年份:2023